<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37998081</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2313-433X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of imaging</Title><ISOAbbreviation>J Imaging</ISOAbbreviation></Journal><ArticleTitle>Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jimaging9110234</ELocationID><Abstract><AbstractText>Several optical coherence tomography angiography (OCT-A) studies have demonstrated retinal microvascular changes in patients post-SARS-CoV-2 infection, reflecting retinal-systemic microvasculature homology. Post-COVID-19 syndrome (PCS) entails persistent symptoms following SARS-CoV-2 infection. In this study, we investigated the retinal microvasculature in PCS patients using OCT-angiography and analysed the macular retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) thickness via spectral domain-OCT (SD-OCT). Conducted at the Manchester Royal Eye Hospital, UK, this cross-sectional study compared 40 PCS participants with 40 healthy controls, who underwent ophthalmic assessments, SD-OCT, and OCT-A imaging. OCT-A images from the superficial capillary plexus (SCP) were analysed using an in-house specialised software, OCT-A vascular image analysis (OCTAVIA), measuring the mean large vessel and capillary intensity, vessel density, ischaemia areas, and foveal avascular zone (FAZ) area and circularity. RNFL and GCL thickness was measured using the OCT machine's software. Retinal evaluations occurred at an average of 15.2 &#xb1; 6.9 months post SARS-CoV-2 infection in PCS participants. Our findings revealed no significant differences between the PCS and control groups in the OCT-A parameters or RNFL and GCL thicknesses, indicating that no long-term damage ensued in the vascular bed or retinal layers within our cohort, providing a degree of reassurance for PCS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noor</LastName><ForeName>Maha</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1486-469X</Identifier><AffiliationInfo><Affiliation>Department of Eye Research, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGrath</LastName><ForeName>Orlaith</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4302-7081</Identifier><AffiliationInfo><Affiliation>Department of Eye Research, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drira</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Eye Research, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ophtalmologie D&#xe9;partement, Centre Hospitalier Universitaire de Toulouse, 31300 Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslam</LastName><ForeName>Tariq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Eye Research, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Imaging</MedlineTA><NlmUniqueID>101698819</NlmUniqueID><ISSNLinking>2313-433X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SD-OCT</Keyword><Keyword MajorTopicYN="N">ganglion cell layer</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">nerve fibre layer</Keyword><Keyword MajorTopicYN="N">optical coherence tomography angiography (OCT-A)</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome (PCS)</Keyword><Keyword MajorTopicYN="N">retina</Keyword></KeywordList><CoiStatement>Dr Maha Noor, Dr Orlaith McGrath, and Dr Ines Drira declare that they have no personal, financial, commercial, or academic conflict of interest. Professor Tariq M. Aslam has received funding and educational grants from Bayer, Novartis, Roche, Allergan, Laboratoires, Thea, Oraya, and Bausch and Lomb, Topcon, Heidelberg, Canon. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37998081</ArticleId><ArticleId IdType="pmc">PMC10672226</ArticleId><ArticleId IdType="doi">10.3390/jimaging9110234</ArticleId><ArticleId IdType="pii">jimaging9110234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health and Care Excellence (NICE)   COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE; Sutton-in-Ashfield, UK: 2021.  [(accessed on 3 March 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) eLife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: Hypothesized mechanisms and potential therapeutic approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ramadan A., Rabab&#x2019;h O., Shah J., Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19. Neurol. Int. 2021;13:102&#x2013;119. doi: 10.3390/neurolint13010010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint13010010</ArticleId><ArticleId IdType="pmc">PMC8006051</ArticleId><ArticleId IdType="pubmed">33803475</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., A Kulkarni P. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect. Dis. 2020;7:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo-Mart&#xed;nez W., Lozada-Mart&#xed;nez I., Escobar-Collazos A., Navarro-Coronado A., Moscote-Salazar L., Pacheco-Hern&#xe1;ndez A., Janjua T., Bosque-Varela P. Post-COVID 19 neurological syndrome: Implications for sequelae&#x2019;s treatment. J. Clin. Neurosci. 2021;88:219&#x2013;225. doi: 10.1016/j.jocn.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8031003</ArticleId><ArticleId IdType="pubmed">33992187</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J. Post-COVID-19 syndrome: Epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev. Nuerol. 2021;72:384&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., Ryerson C.J., Guenette J.A. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2018;The long tail of COVID-19&#x2019;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000 Res. 2021;9:1349. doi: 10.12688/f1000research.27287.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.G., Peterson D., Armstrong J., Knox K., Roy A. Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases. Infect. Agent Cancer. 2023;18:7. doi: 10.1186/s13027-023-00485-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-023-00485-z</ArticleId><ArticleId IdType="pmc">PMC9902840</ArticleId><ArticleId IdType="pubmed">36750846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade B.S., Siqueira S., Soares W.R.d.A., Rangel F.d.S., Santos N.O., Freitas A.d.S., da Silveira P.R., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.C., Nallani R., Cass L., Bhalla V., Chiu A.G., Villwock J.A. A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic. Am. J. Rhinol. Allergy. 2020;35:323&#x2013;333. doi: 10.1177/1945892420957853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420957853</ArticleId><ArticleId IdType="pmc">PMC10404900</ArticleId><ArticleId IdType="pubmed">32915650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Morrone M.C., Patrono C., Santoro M.G., Schiaffino S., Remuzzi G., Bussolati G., Cappuccinelli P. Long Covid: Where we stand and challenges ahead. Cell Death Differ. 2022;29:1891&#x2013;1900. doi: 10.1038/s41418-022-01052-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland A.J., Yousuf M.S., Shiers S., Price T.J. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: Implications for COVID-19 and pain.  [(accessed on 15 March 2023)];Pain Rep. 2021 6:e885. doi: 10.1097/PR9.0000000000000885. Available online:  https://journals.lww.com/painrpts/Fulltext/2021/01000/Neurobiology_of_SARS_CoV_2_interactions_with_the.1.aspx.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000885</ArticleId><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.-J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., Chung K.F. Confronting COVID-19-associated cough and the post-COVID syndrome: Role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir. Med. 2021;9:533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Scarioni M., Di Lorenzo F., Hort J., Georges J., Tomic S., Nobili F., Frederiksen K.S., the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. J. Alzheimer&#x2019;s Dis. 2021;82:883&#x2013;898. doi: 10.3233/JAD-210335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210335</ArticleId><ArticleId IdType="pubmed">34092646</ArticleId></ArticleIdList></Reference><Reference><Citation>Touyz R.M., Boyd M.O., Guzik T., Padmanabhan S., McCallum L., Delles C., Mark P.B., Petrie J.R., Rios F., Montezano A.C., et al. Cardiovascular and Renal Risk Factors and Complications Associated with COVID-19. CJC Open. 2021;3:1257&#x2013;1272. doi: 10.1016/j.cjco.2021.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8205551</ArticleId><ArticleId IdType="pubmed">34151246</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., O&#x2019;Farrelly C., Conlon N., Bourke N.M., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.W., Fan B.E., Huang W., Chia Y.W. ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. Ann. Acad. Med. Singap. 2021;50:425&#x2013;430. doi: 10.47102/annals-acadmedsg.202175.</Citation><ArticleIdList><ArticleId IdType="doi">10.47102/annals-acadmedsg.202175</ArticleId><ArticleId IdType="pubmed">34100519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Pellicer-Valero O.J., Navarro-Pardo E., Palacios-Ce&#xf1;a D., Florencio L.L., Guijarro C., Mart&#xed;n-Guerrero J.D. Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study. Int. J. Infect. Dis. 2022;116:241&#x2013;244. doi: 10.1016/j.ijid.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson N.S., Jenkins G., Hart N. COVID-19 and what comes after? Thorax. 2021;76:324. doi: 10.1136/thoraxjnl-2020-216226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216226</ArticleId><ArticleId IdType="pubmed">33589513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al.  Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection.  [(accessed on 15 March 2023)];Front. Med. 2021 8:754667. doi: 10.3389/fmed.2021.754667. Available online:  https://www.frontiersin.org/articles/10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson M.M., Qasmieh S.A., Kulkarni S.G., Teasdale C.A., Jones H.E., McNairy M., Borrell L.N., Nash D. The Epidemiology of Long COVID in US Adults. Clin. Infect. Dis. 2022;76:1636&#x2013;1645. doi: 10.1093/cid/ciac961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac961</ArticleId><ArticleId IdType="pubmed">36542514</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E., et al. Post-COVID-19 Syndrome in Outpatients: A Cohort Study. J. Gen. Intern. Med. 2022;37:1943&#x2013;1952. doi: 10.1007/s11606-021-07242-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S.W., Abbafati C., Aerts J. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022 doi: 10.1101/2022.05.26.22275532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS)   Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 2 February 2023. Office for National Statistics (ONS) Website, Statistical Bulletin; London, UK: 2023.  [(accessed on 15 March 2023)].  Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomi N., Sindhuja K., Asif M., Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J. Ophthalmol. 2020;68:1546&#x2013;1550. doi: 10.4103/ijo.IJO_1319_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_1319_20</ArticleId><ArticleId IdType="pmc">PMC7640841</ArticleId><ArticleId IdType="pubmed">32709772</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa F., Bonif&#xe1;cio L.P., Bellissimo-Rodrigues F., Rocha E.M., Jorge R., Bollela V.R., Antunes-Foschini R. Ocular findings among patients surviving COVID-19. Sci. Rep. 2021;11:11085. doi: 10.1038/s41598-021-90482-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90482-2</ArticleId><ArticleId IdType="pmc">PMC8155146</ArticleId><ArticleId IdType="pubmed">34040094</ArticleId></ArticleIdList></Reference><Reference><Citation>Honavar S., Sen M., Sharma N., Sachdev M. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J. Ophthalmol. 2021;69:488&#x2013;509. doi: 10.4103/ijo.IJO_297_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_297_21</ArticleId><ArticleId IdType="pmc">PMC7942063</ArticleId><ArticleId IdType="pubmed">33595463</ArticleId></ArticleIdList></Reference><Reference><Citation>Feizi S.M., Meshksar A., Naderi A., Esfandiari H. Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases. Cornea. 2021;40:1204&#x2013;1206. doi: 10.1097/ICO.0000000000002795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICO.0000000000002795</ArticleId><ArticleId IdType="pmc">PMC8330625</ArticleId><ArticleId IdType="pubmed">34351874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoli F., Veritti D., Danese C., Samassa F., Sarao V., Rassu N., Gambato T., Lanzetta P. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. J. Ophthalmol. 2020;2020:4827304. doi: 10.1155/2020/4827304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/4827304</ArticleId><ArticleId IdType="pmc">PMC7491448</ArticleId><ArticleId IdType="pubmed">32963819</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo K.Y., Invernizzi A., Staurenghi G., Cheung C.M.G. COVID-19-Related Retinal Micro-vasculopathy&#x2014;A Review of Current Evidence. Arch. Ophthalmol. 2021;235:98&#x2013;110. doi: 10.1016/j.ajo.2021.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.09.019</ArticleId><ArticleId IdType="pmc">PMC8465265</ArticleId><ArticleId IdType="pubmed">34587494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Kannan N.B., Kumar J., Rajan R.P., Kumar K., Baliga G., Reddy H., Upadhyay A., Ramasamy K. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: A systematic review. Int. Ophthalmol. 2022;42:323&#x2013;336. doi: 10.1007/s10792-021-01996-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01996-7</ArticleId><ArticleId IdType="pmc">PMC8356207</ArticleId><ArticleId IdType="pubmed">34379290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim R., Cheung G., Ting D., Wong E., Wong T.Y., Yeo I., Wong C.W. Retinal microvascular signs in COVID-19. Br. J. Ophthalmol. 2022;106:1308&#x2013;1312. doi: 10.1136/bjophthalmol-2020-318236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-318236</ArticleId><ArticleId IdType="pubmed">33741583</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho P.M., Marcos A.A.A., Romano A.C., Nascimento H., Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. doi: 10.1016/S0140-6736(20)31014-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31014-X</ArticleId><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavvas D.G., Sarraf D., Sadda S.R., Eliott D., Ehlers J.P., Waheed N.K., Morizane Y., Sakamoto T., Tsilimbaris M., Miller J.B. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye. 2020;34:2153&#x2013;2154. doi: 10.1038/s41433-020-1084-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-020-1084-9</ArticleId><ArticleId IdType="pmc">PMC7347265</ArticleId><ArticleId IdType="pubmed">32647303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang P., Zhang X., Peng Y., Jiang B. Seeking clarity on retinal findings in patients with COVID-19. Lancet. 2020;396:e35. doi: 10.1016/S0140-6736(20)31921-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31921-8</ArticleId><ArticleId IdType="pmc">PMC7498247</ArticleId><ArticleId IdType="pubmed">32950097</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos-Blasco B., G&#xfc;emes-Villahoz N., Vidal-Villegas B., Martinez-De-La-Casa J.M., Donate-Lopez J., Mart&#xed;n-S&#xe1;nchez F.J., Gonz&#xe1;lez-Armengol J.J., Porta-Etessam J., Martin J.L.R., Garcia-Feijoo J. Optic nerve and macular optical coherence tomography in recovered COVID-19 patients. Eur. J. Ophthalmol. 2022;32:628&#x2013;636. doi: 10.1177/11206721211001019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11206721211001019</ArticleId><ArticleId IdType="pubmed">33719624</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi Beni A., Dehghani A., Kianersi F., Ghanbari H., Habibidastenae Z., Memarzadeh S.E., Beni Z.N. Retinal findings of COVID-19 patients using ocular coherence tomography angiography two to three months after infection: Ocular appearance recovered COVID-19 patient. Photodiagnos. Photodyn. Ther. 2022;38:102726. doi: 10.1016/j.pdpdt.2022.102726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.102726</ArticleId><ArticleId IdType="pmc">PMC8762816</ArticleId><ArticleId IdType="pubmed">35051664</ArticleId></ArticleIdList></Reference><Reference><Citation>Oren B., Aydem&#x131;r G.A., Aydem&#x131;r E., Atesoglu H.I., Goker Y.S., K&#x131;z&#x131;ltoprak H., Ozcel&#x131;k K.C. Quantitative assessment of retinal changes in COVID-19 patients. Clin. Exp. Optom. 2021;104:717&#x2013;722. doi: 10.1080/08164622.2021.1916389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08164622.2021.1916389</ArticleId><ArticleId IdType="pubmed">34016010</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi L., Plateroti P., Balducci S., Bollanti L., Conti F.G., Vitale M., Recupero S.M., Enrici M.M., Fenicia V., Pugliese G. Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: A sign of diabetic polyneuropathy, not retinopathy. J. Diabetes Complicat. 2016;30:469&#x2013;476. doi: 10.1016/j.jdiacomp.2015.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2015.12.025</ArticleId><ArticleId IdType="pubmed">26809902</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton N., Aslam T., MacGillivray T., Pattie A., Deary I.J., Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J. Anat. 2005;206:319&#x2013;348. doi: 10.1111/j.1469-7580.2005.00395.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7580.2005.00395.x</ArticleId><ArticleId IdType="pmc">PMC1571489</ArticleId><ArticleId IdType="pubmed">15817102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata M.&#xc1;., Banderas Garc&#xed;a S., S&#xe1;nchez-Moltalv&#xe1; A., Falc&#xf3; A., Otero-Romero S., Arcos G., Velazquez-Villoria D., Garc&#xed;a-Arum&#xed; J. Retinal microvascular abnor-malities in patients after COVID-19 depending on disease severity. Br. J. Ophthalmol. 2022;106:559. doi: 10.1136/bjophthalmol-2020-317953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317953</ArticleId><ArticleId IdType="pubmed">33328184</ArticleId></ArticleIdList></Reference><Reference><Citation>Turker I.C., Dogan C.U., Guven D., Kutucu O.K., Gul C. Optical coherence tomography angiography findings in patients with COVID-19. Can. J. Ophthalmol. 2021;56:83&#x2013;87. doi: 10.1016/j.jcjo.2020.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.12.021</ArticleId><ArticleId IdType="pmc">PMC7833266</ArticleId><ArticleId IdType="pubmed">33497612</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Emamverdian Z., Shoeibi N., Omidtabrizi A., Daneshvar R., Rezvani T.S., Saeedian N., Eslami S., Mazloumi M., Sadda S., et al. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: A case-control study. Can. J. Ophthalmol. 2021;56:24&#x2013;30. doi: 10.1016/j.jcjo.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7666612</ArticleId><ArticleId IdType="pubmed">33249111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Zamora J., Bilbao-Malav&#xe9; V., G&#xe1;ndara E., Casablanca-Pi&#xf1;era A., Boquera-Ventosa C., Landecho M.F., Zarranz-Ventura J., Garc&#xed;a-Layana A. Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:247. doi: 10.3390/biomedicines9030247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030247</ArticleId><ArticleId IdType="pmc">PMC7998142</ArticleId><ArticleId IdType="pubmed">33801324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazar L., Karahan M., Vural E., Ava S., Erdem S., Dursun M.E., Keklik&#xe7;i U. Macular vessel density in patients recovered from COVID 19. Photodiagnos. Photodyn. Ther. 2021;34:102267. doi: 10.1016/j.pdpdt.2021.102267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2021.102267</ArticleId><ArticleId IdType="pmc">PMC7999941</ArticleId><ArticleId IdType="pubmed">33785439</ArticleId></ArticleIdList></Reference><Reference><Citation>Guemes-Villahoz N., Burgos-Blasco B., Vidal-Villegas B., Donate-L&#xf3;pez J., de la Muela M.H., L&#xf3;pez-Guajardo L., Mart&#xed;n-S&#xe1;nchez F.J., Garc&#xed;a-Feijo&#xf3; J. Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2021;259:2243&#x2013;2249. doi: 10.1007/s00417-021-05186-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05186-0</ArticleId><ArticleId IdType="pmc">PMC8102150</ArticleId><ArticleId IdType="pubmed">33961108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodman J., Ferraz M., Baran A., Zhang B. Optical coherence tomography angiography of retinal vasculature in recovered COVID-19 patients compared to age and ethnic matched controls. Clin. Exp. Optom. 2022;105:842&#x2013;847. doi: 10.1080/08164622.2021.1978817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08164622.2021.1978817</ArticleId><ArticleId IdType="pubmed">34751081</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz &#xc7;ebi A., K&#x131;l&#x131;&#xe7;arslan O., U&#xe7;ar D. Evaluation of Retinal Microvascular Impairment after COVID-19 and Its Clinical Correlates Using Optical Coherence Tomography Angiography. Turk. J. Ophthalmol. 2022;52:324&#x2013;330. doi: 10.4274/tjo.galenos.2022.87036.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tjo.galenos.2022.87036</ArticleId><ArticleId IdType="pmc">PMC9631506</ArticleId><ArticleId IdType="pubmed">36317806</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetinkaya T., Kurt M.M., Akpolat C. Analysis of swept-source optical coherence tomography angiography measurement al-terations in adult patients recovered from COVID-19. Clin. Exp. Optom. 2022;105:848&#x2013;852. doi: 10.1080/08164622.2021.1999770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08164622.2021.1999770</ArticleId><ArticleId IdType="pubmed">34875203</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Hassanpour K., Hosseini S., Emamverdian Z., Ansari-Astaneh M.R., Zamani G., Gharib B., Abrishami M. Macular vessel density re-duction in patients recovered from COVID-19: A longitudinal optical coherence tomography angiography study. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2022;260:771&#x2013;779. doi: 10.1007/s00417-021-05429-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05429-0</ArticleId><ArticleId IdType="pmc">PMC8505785</ArticleId><ArticleId IdType="pubmed">34636996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nageeb Louz R.E., Salah Eddin M.A., Macky T.A., Tolba D.A.A. Post COVID-19 Retinal Evaluation Using Optical Coherence Tomography Angiography: A Case Control Study. Ocul. Immunol. Inflamm. 2022;31:1175&#x2013;1183. doi: 10.1080/09273948.2022.2141651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2022.2141651</ArticleId><ArticleId IdType="pubmed">36413337</ArticleId></ArticleIdList></Reference><Reference><Citation>Cennamo G., Reibaldi M., Montorio D., D&#x2019;Andrea L., Fallico M., Triassi M. Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study. Am. J. Ophthalmol. 2021;227:182&#x2013;190. doi: 10.1016/j.ajo.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.03.015</ArticleId><ArticleId IdType="pmc">PMC7997850</ArticleId><ArticleId IdType="pubmed">33781767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao-Malav&#xe9; V., Gonz&#xe1;lez-Zamora J., de Viteri M.S., de la Puente M., G&#xe1;ndara E., Casablanca-Pi&#xf1;era A., Boquera-Ventosa C., Zarranz-Ventura J., Landecho M.F., Garc&#xed;a-Layana A. Persistent Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia at 6-Months Follow-Up Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:502. doi: 10.3390/biomedicines9050502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9050502</ArticleId><ArticleId IdType="pmc">PMC8147391</ArticleId><ArticleId IdType="pubmed">34063291</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a S.B., Arag&#xf3;n D., Azarfane B., Trejo F., Garrell-Salat X., S&#xe1;nchez-Montalv&#xe1; A., Otero-Romero S., Garcia-Arumi J., Zapata M.A. Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease. BMJ Open Ophthalmol. 2022;7:e000867. doi: 10.1136/bmjophth-2021-000867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjophth-2021-000867</ArticleId><ArticleId IdType="pmc">PMC8753095</ArticleId><ArticleId IdType="pubmed">35039796</ArticleId></ArticleIdList></Reference><Reference><Citation>E Murdoch I., Morris S.S., Cousens S.N. People and eyes: Statistical approaches in ophthalmology. Br. J. Ophthalmol. 1998;82:971&#x2013;973. doi: 10.1136/bjo.82.8.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.82.8.971</ArticleId><ArticleId IdType="pmc">PMC1722711</ArticleId><ArticleId IdType="pubmed">9828786</ArticleId></ArticleIdList></Reference><Reference><Citation>Czak&#xf3; C., Istv&#xe1;n L., Beny&#xf3; F., &#xc9;l&#x151; &#xc1;., Erdei G., Horv&#xe1;th H., Nagy Z.Z., Kov&#xe1;cs I. The Impact of Deterministic Signal Loss on OCT Angiography Measurements. Transl. Vis. Vision Sci. Technol. 2020;9:10. doi: 10.1167/tvst.9.5.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/tvst.9.5.10</ArticleId><ArticleId IdType="pmc">PMC7401964</ArticleId><ArticleId IdType="pubmed">32821482</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Treatment Diabetic Retinopathy Study Research Group Early Photocoagulation for Diabetic Retinopathy: ETDRS Report Number 9. Ophthalmology. 1991;98:766&#x2013;785. doi: 10.1016/S0161-6420(13)38011-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-6420(13)38011-7</ArticleId><ArticleId IdType="pubmed">2062512</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam T.M., Hoyle D.C., Puri V., Bento G. Differentiation of Diabetic Status Using Statistical and Machine Learning Techniques on Optical Coherence Tomography Angiography Images. Transl. Vis. Sci. Technol. 2020;9:2. doi: 10.1167/tvst.9.4.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/tvst.9.4.2</ArticleId><ArticleId IdType="pmc">PMC7396193</ArticleId><ArticleId IdType="pubmed">32818090</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson I.A., Durrani A.K., Patel S. Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy. Eye. 2019;33:648&#x2013;652. doi: 10.1038/s41433-018-0286-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-018-0286-x</ArticleId><ArticleId IdType="pmc">PMC6461750</ArticleId><ArticleId IdType="pubmed">30510234</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastropasqua R., Toto L., Mastropasqua A., Aloia R., De Nicola C., A Mattei P., Di Marzio G., Di Nicola M., Di Antonio L. Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography. Int. J. Ophthalmol. 2017;10:1545&#x2013;1551. doi: 10.18240/ijo.2017.10.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.18240/ijo.2017.10.11</ArticleId><ArticleId IdType="pmc">PMC5638976</ArticleId><ArticleId IdType="pubmed">29062774</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawitz B.D., Mo S., Geyman L.S., Agemy S.A., Scripsema N.K., Garcia P.M., Chui T.Y., Rosen R.B. Acircularity index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls measured by optical coherence tomography angiography. Vis. Res. 2017;139:177&#x2013;186. doi: 10.1016/j.visres.2016.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.visres.2016.09.019</ArticleId><ArticleId IdType="pubmed">28212983</ArticleId></ArticleIdList></Reference><Reference><Citation>The Jamovi Project [Computer Software] 2021.  [(accessed on 1 January 2020)].  Available online:  http://www.jamovi.org.</Citation></Reference><Reference><Citation>National Institute of Health and Care Excellence (NICE)   COVID-19 Rapid Evidence Review: Risk Factors for Long-Term Effects of COVID-19. NICE; Sutton-in-Ashfield, UK: 2021.  [(accessed on 15 March 2023)].  Available online:  https://files.magicapp.org/guideline/08d10c67-1331-4146-9471-b15d1d93e707/files/Evidence_review_for_risk_factors_FINAL_r400881.pdf.</Citation></Reference><Reference><Citation>Mavi Yildiz A., Ucan Gunduz G., Yalcinbayir O., Acet Ozturk N.A., Avci R., Coskun F. SD-OCT assessment of macular and optic nerve alterations in patients recovered from COVID-19. Can. J. Ophthalmol. 2022;57:75&#x2013;81. doi: 10.1016/j.jcjo.2021.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2021.06.019</ArticleId><ArticleId IdType="pmc">PMC8255111</ArticleId><ArticleId IdType="pubmed">34303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugurlu A., Agcayazi S.B., Icel E., Budakoglu O., Unver E., Barkay O., Karake&#xe7;ili F., Bayrakceken K. Assessment of the optic nerve, macular, and retinal vascular effects of COVID-19. Can. J. Ophthalmol. 2022.  [(accessed on 24 April 2023)].  Available online:  https://www.sciencedirect.com/science/article/pii/S0008418222001892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242884</ArticleId><ArticleId IdType="pubmed">35868440</ArticleId></ArticleIdList></Reference><Reference><Citation>Taskiran-Sag A., Eroglu E., Ozulken K., Canlar S., Poyraz B.M., Sekerlisoy M.B., Mumcuoglu T. Headache and cognitive disturbance correlate with ganglion cell layer thickness in patients who recovered from COVID-19. Clin. Neurol. Neurosurg. 2022;217:107263. doi: 10.1016/j.clineuro.2022.107263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2022.107263</ArticleId><ArticleId IdType="pmc">PMC9040445</ArticleId><ArticleId IdType="pubmed">35525105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanra A.Y., Alt&#x131;nel M.G., Alparslan F. Evaluation of retinal and choroidal parameters as neurodegeneration biomarkers in patients with post-COVID-19 syndrome. Photodiagnos. Photodyn. Ther. 2022;40:103108. doi: 10.1016/j.pdpdt.2022.103108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.103108</ArticleId><ArticleId IdType="pubmed">36075519</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlick S., Lucio M., Wallukat G., Bartsch A., Skornia A., Hoffmanns J., Szewczykowski C., Schr&#xf6;der T., Raith F., Rogge L., et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022;23:13683. doi: 10.3390/ijms232213683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="pubmed">36430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K., Megli&#x10d; A., Lapajne L., Logar M., Valentin&#x10d;i&#x10d; N.V., Petrovi&#x10d; M.G., Mekjavi&#x107; P.J. The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging&#x2014;A Prospective Longitudinal Cohort Study. Int. J. Mol. Sci. 2023;24:4032. doi: 10.3390/ijms24044032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24044032</ArticleId><ArticleId IdType="pmc">PMC9966689</ArticleId><ArticleId IdType="pubmed">36835445</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K., Mekjavic P.J., Valentincic N.V., Petrovski G., Petrovic M.G. An Update on COVID-19 Related Ophthalmic Manifestations. Ocul. Immunol. Inflamm. 2021;29:684&#x2013;689. doi: 10.1080/09273948.2021.1896008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2021.1896008</ArticleId><ArticleId IdType="pubmed">33826465</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida-Pititto B., Dualib P.M., Zajdenverg L., Dantas J.R., de Souza F.D., Rodacki M., Bertoluci M.C., Brazilian Diabetes Society Study Group (SBD) Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol. Metab. Syndr. 2020;12:75. doi: 10.1186/s13098-020-00586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-020-00586-4</ArticleId><ArticleId IdType="pmc">PMC7456786</ArticleId><ArticleId IdType="pubmed">32874207</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano M.C., Gambini G., Cozzupoli G.M., Crincoli E., Savastano A., De Vico U., Culiersi C., Falsini B., Martelli F., Minnella A.M., et al. Retinal capillary involvement in early post-COVID-19 patients: A healthy controlled study. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2021;259:2157&#x2013;2165. doi: 10.1007/s00417-020-05070-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-020-05070-3</ArticleId><ArticleId IdType="pmc">PMC7848665</ArticleId><ArticleId IdType="pubmed">33523252</ArticleId></ArticleIdList></Reference><Reference><Citation>Szkodny D., Wyl&#x119;ga&#x142;a E., Sujka-Franczak P., Chlasta-Twardzik E., Fiolka R., Tomczyk T., Wyl&#x119;ga&#x142;a A. Retinal OCT Findings in Patients after COVID Infection. J. Clin. Med. 2021;10:3233. doi: 10.3390/jcm10153233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153233</ArticleId><ArticleId IdType="pmc">PMC8347407</ArticleId><ArticleId IdType="pubmed">34362017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal M., Winiarczyk M., Cie&#x15b;la E., P&#x142;atkowska-Adamska B., Walczyk A., Biskup M., Pabjan P., G&#x142;uszek S., Odrobina D., Mackiewicz J., et al. Retinal Microvascular Changes in COVID-19 Bilateral Pneumonia Based on Optical Coherence Tomography Angiography. J. Clin. Med. 2022;11:3621. doi: 10.3390/jcm11133621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133621</ArticleId><ArticleId IdType="pmc">PMC9267319</ArticleId><ArticleId IdType="pubmed">35806907</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiosi F., Campagna G., Rinaldi M., Manzi G., Dell&#x2019;Omo R., Fiorentino G., Toro M., Tranfa F., D&#x2019;Andrea L., Rejdak M., et al.  Optical Coherence Tomography Angiography Analysis of Vessel Density Indices in Early Post-COVID-19 Patients.  [(accessed on 24 April 2023)];Front. Med. 2022 9:927121. doi: 10.3389/fmed.2022.927121. Available online:  https://www.frontiersin.org/articles/10.3389/fmed.2022.927121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.927121</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.927121</ArticleId><ArticleId IdType="pmc">PMC9273855</ArticleId><ArticleId IdType="pubmed">35836940</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>